Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Environ Monit ; 2(5): 432-5, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11254045

RESUMEN

A method has been developed for the atmospheric sampling and analysis of four perfluorocarbon tracer (PFT) compounds simultaneously at the parts per trillion (ppt) level. PFTs were pre-concentrated using adsorbent tube air sampling. Analysis was achieved by thermal desorption (TD) and gas chromatography (GC) with electron capture detection (ECD). Efficient separation of the PFTs from the other sample constituents was achieved by use of a capillary porous layer open tubular (PLOT) GC column without the need to cool the GC oven to sub-ambient temperatures using liquid coolants (M. de Bortoli and E. Pecchio, J. High Resolut. Chromatogr., 1985, 8, 422) or for a catalytic destruction step to remove interferents (T. W. D'Ottavio, R. W. Goodrich and R. N. Dietz, Environ. Sci. Technol., 1986, 20, 100). Results from test field trials with two volatile PFTs that were buried to simulate an underground leaking cable were successful. The PFTs were detected above ground level to pinpoint the leak position. The highest tracer concentrations were detected within 1 m of the simulated leak positions 2 days after tracer burial. The developed technology was applied to an oil leaking high voltage electricity cable. One PFT was added to the cable oil which enabled detection of the oil leak to within 3 m. The reported method has many advantages over currently used leak detection methods and could, in the future, be applied to the detection of underground leaks in a variety of cables and pipes.


Asunto(s)
Monitoreo del Ambiente/métodos , Fluorocarburos/análisis , Contaminantes del Suelo/análisis , Cromatografía de Gases , Petróleo
2.
Transgenic Res ; 6(2): 157-68, 1997 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9090063

RESUMEN

The tissue-specific, developmental, and genetic control of four endosperm-active genes was studied via expression of GUS reporter genes in transgenic maize plants. The transgenes included promoters from the maize granule-bound starch synthase (Waxy) gene (zmGBS), a maize 27 kDa zein gene (zmZ27), a rice small subunit ADP-glucose pyrophosphorylase gene (osAGP) and the rice glutelin 1 gene (osGT1). Most plants had a transgene expression profile similar to that of the endogenous gene: expression in the pollen and endosperm for the zmGBS transgene, and endosperm only for the others. Histological analysis indicated expression initiated at the periphery of the endosperm for zmGBS, zmZ27 and osGT1, while osAGP transgene activity tended to start in the lower portion of the seed. Transgene expression at the RNA level was proportional to GUS activity, and did not influence endogenous gene expression. Genetic analysis showed that there was a positive dosage response with most lines. Activity of the zmGBS transgene was threefold higher in a low starch (shrunken 2) genetic background. This effect was not seen with zmZ27 or osGTI transgenes. The expression of the transgenes is discussed relative to the known behaviour of the endogenous genes, and the developmental programme of the maize endosperm.


Asunto(s)
Regulación de la Expresión Génica de las Plantas , Glútenes/genética , Nucleotidiltransferasas/genética , Oryza/genética , Proteínas de Plantas/genética , Almidón Sintasa/genética , Zea mays/genética , Zeína/genética , Southern Blotting , Clonación Molecular , Sondas de ADN , Dosificación de Gen , Genes Reporteros , Glucosa-1-Fosfato Adenililtransferasa , Glútenes/metabolismo , Hibridación de Ácido Nucleico , Nucleotidiltransferasas/metabolismo , Proteínas de Plantas/metabolismo , Plantas Modificadas Genéticamente , Polen/genética , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas , ARN de Planta/análisis , ARN de Planta/genética , Semillas/genética , Almidón Sintasa/metabolismo , Transcripción Genética , Transgenes , Zeína/metabolismo
3.
Brain Res ; 683(2): 172-8, 1995 Jun 19.
Artículo en Inglés | MEDLINE | ID: mdl-7552352

RESUMEN

Recently messenger RNA (mRNA) for glial derived neurotrophic factor (GDNF), a recently discovered member of the TGF-beta superfamily, was shown to increase in the hippocampus after kainic acid-induced seizures. The possibility that exogenous recombinant human (rh) GDNF may have anticonvulsant properties was investigated using a model of temporal lobe epilepsy in the rat. rhGDNF, vehicle or inactive rhGDNF were injected intracerebroventricularly 1 h before peripheral administration of kainic acid. rhGDNF suppressed kainic acid-induced tonic-clonic convulsions when compared to animals treated with vehicle or inactive rhGDNF. The inhibition of kainic acid-induced seizure activity by rhGDNF also prevented the associated neuronal cell loss in hippocampal, thalamic and amygdaloid regions. These results suggest that rhGDNF should be evaluated in other seizure and acute neural disorders that are associated with excitotoxic processes.


Asunto(s)
Factores de Crecimiento Nervioso/farmacología , Proteínas del Tejido Nervioso/farmacología , Convulsiones/tratamiento farmacológico , Fibras Adrenérgicas/fisiología , Amígdala del Cerebelo/citología , Amígdala del Cerebelo/fisiopatología , Animales , Recuento de Células , Embrión de Pollo , Factor Neurotrófico Derivado de la Línea Celular Glial , Hipocampo/citología , Hipocampo/fisiopatología , Inyecciones Intraventriculares , Ácido Kaínico , Masculino , Ratas , Ratas Endogámicas F344 , Proteínas Recombinantes/farmacología , Convulsiones/inducido químicamente , Tálamo/citología , Tálamo/fisiopatología
4.
Am J Trop Med Hyg ; 24(3): 485-95, 1975 May.
Artículo en Inglés | MEDLINE | ID: mdl-1098496

RESUMEN

Acedapsone (DADDS), a repository sulfone given by injection five times a year, has been used since 1967 for the treatment of all leprosy patients in the Karimui, an area of diffic-lt access. More than 460 patients have been treated, 336 beginning in November 1967 and continuing through the latest assessment 6 years later. The injections have been well received and they have been administered very regularly. Clinical observations were begun before 1967, as a base-line of assessments was available for the patients whose disease appeared before that time. The response to DADDS therapy has been satisfactory except in 5 of the 28 multibacillary patients in whose smears solid-staining Mycobacterium leprae have reappeared. M. leprae was isolated in mice from three of these patients; one strain has been proven to be completely susceptible to dapsone (DDS), and the other two very probably are. DDS levels in the plasma of these five patients were normal and well above the minimal inhibitory concentration. The most probable explanation is that a few viable M. leprae survived in the presence of inhibitory concentrations of DDS for the 4 to 6 years during which dead bacilli were disintegrating and disappearing from the tissues. The other 23 multibacillary patients responded satisfactorily. The decrease in the number of M. leprae in the skin smears has been most prompt in patients with low initial bacterial loads and in those with borderline lepromatous diagnoses. A high initial bacterial load and a fully lepromatous diagnosis were associated with a slow initial loss of M. leprae in the 1st year, followed by a more rapid loss the next year. All of the multibacillary patients have now been treated by the addition of a 90-day course of rifampicin.


Asunto(s)
Dapsona/análogos & derivados , Dapsona/uso terapéutico , Leprostáticos/uso terapéutico , Lepra/tratamiento farmacológico , Rifampin/uso terapéutico , Acetamidas/uso terapéutico , Adolescente , Adulto , Anciano , Infecciones Bacterianas/complicaciones , Niño , Preescolar , Ensayos Clínicos como Asunto , Formas de Dosificación , Femenino , Humanos , Lactante , Leprostáticos/administración & dosificación , Leprostáticos/efectos adversos , Lepra/complicaciones , Lepra/diagnóstico , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Mycobacterium leprae/efectos de los fármacos , Nueva Guinea , Recurrencia , Remisión Espontánea , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA